Michael Gosk
@General Atlantic, L.p.
Latest period2024 - Q3ReportedManaged Assets$3.517BTotal holdings18
Assets growth rate10.63%Assets growth rate (2-Q avg)-7.76%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in General Atlantic, L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 18 positions.
Assets under management
The assets under management (AUM) of General Atlantic, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.517B in assets, with a quarterly growth rate of 10.63% and a 2-quarter average growth rate of -7.76%. The portfolio is managed by Michael Gosk, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
RPRXRoyalty Pharma
| 1.21% | $42.435M 1.5M shares@ $28.29 avg price | |
THRDThird Harmonic Bio
| 1.14% | $40.091M 2.959M shares@ $13.55 avg price | |
IMCRImmunocore
| 1.12% | $39.276M 1.262M shares@ $31.14 avg price | |
RSKDRiskified
| 0.72% | $25.187M 5.325M shares@ $4.74 avg price | |
SLRNAcelyrin
| 0.41% | $14.246M 2.89M shares@ $4.93 avg price | |
LOGCWish
| 0.1% | $3.322M 609,616 shares@ $5.45 avg price | |
GROVGrove Collaborative
| 0.04% | $1.264M 936,020 shares@ $1.35 avg price | |
ADAGAdagene
| 0.02% | $586,080 264,000 shares@ $2.22 avg price |